BeStock  
Stocks › Biotechnology › SLDB

Solid Biosciences SLDB

US equityMarket cap rank #3471Biotechnology
$6.85 −$0.07 (-1.01%)
Pre-market · Oct 8, 9:00 am ET · After hours $6.85 0.00%
Open$6.76
Prev close$6.92
Day range$6.69 – $6.98
Volume744.7K
Market cap$734.49M
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-3.6x
CheapRich

Near the bottom of its 5-year range · 9th percentile, 5-year average -1.7x

Price / book2.0x
CheapRich

Above its usual level · 77th percentile, 5-year average 1.4x

#2889 of 5317 stocks by PB (1 = cheapest)

Price / sales119.1x
CheapRich

Near the top of its 5-year range · 92nd percentile, 5-year average 44.6x

#4940 of 5146 stocks by PS (1 = cheapest)

P/E over five years

-6x-4x-2x0xOct '21Apr '24Oct '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$9.29
Price vs. fair value-26.3%Trading below the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 1.96 – 1.35 77% (pricier than usual) #2889 of 5317 (1 = cheapest)
PE -3.62 -3.16 -1.74 9% (cheaper than usual) –
PS 119.06 – 44.60 92% (pricier than usual) #4940 of 5146 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Morningstar view

Star rating★★★
Fair value estimate$9.29
Economic moatNone
UncertaintyVery High

Discussion

No comments yet — be the first to weigh in on SLDB.

Leave a comment

Scroll to Top